cefepime has been researched along with Hemorrhage* in 2 studies
1 review(s) available for cefepime and Hemorrhage
| Article | Year |
|---|---|
Spontaneous adrenal hemorrhage during pregnancy: a review of the literature and a case report of successful conservative management.
Spontaneous adrenal hemorrhage is an acute hemorrhage of the adrenal gland that occurs in the absence of trauma or anticoagulant therapy. The incidence of this condition in pregnancy is unknown. We describe a patient with spontaneous unilateral adrenal hemorrhage that occurred during the third trimester of pregnancy. She was successfully managed conservatively with complete resolution of symptoms and had an uncomplicated perinatal outcome. We review the literature on spontaneous adrenal hemorrhage, including clinical signs and symptoms, diagnostic tests, and management of spontaneous adrenal hemorrhage, to help other practitioners to recognize and appropriately treat this rare condition. Topics: Adrenal Gland Diseases; Adult; Cefepime; Cephalosporins; Female; Hemorrhage; Humans; Infant, Newborn; Magnetic Resonance Imaging; Obesity, Morbid; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, Third; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
1 other study(ies) available for cefepime and Hemorrhage
| Article | Year |
|---|---|
Acquired Factor V Deficiency Associated with CFPM Administration.
Acquired factor V deficiency (AFVD) caused by Factor V (FV) inhibition is a rare event, characterized by prolonged prothrombin time and activated partial thromboplastin time. To date, various factors were reported as triggers for developing FV inhibitor. Clinical symptoms range from asymptomatic to life-threatening bleeding. Case Report and Conclusions: Here, we report an 84-year-old Japanese male on hemodialysis due to renal failure who developed subcutaneous hemorrhage after administration of cefepime (CFPM) to treat bacteremia. Deficient FV activity (< 1.0%) was identified and AFVD with FV inhibitor titer of 9 BU/mL was diagnosed. Although the patient had multiple risks for developing FV inhibitor, CFPM was thought to be the major culprit in this case. After the diagnosis, oral prednisolone (30 mg/day) was initiated, but the patient died of respiratory/cardiac failure, unrelated to AFVD. Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Coagulation Tests; Cefepime; Factor V; Factor V Deficiency; Fatal Outcome; Hemorrhage; Humans; Male; Renal Dialysis | 2019 |